LBS-008 clinical trials

An Open-Label, Single-Arm, 3-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease

This study is looking at a new medicine called tinlarebant (LBS-008) for Stargardt Disease. It's a 3-year extension study to see if the medicine is safe and how well people tolerate it over time. Researchers will check for changes in eye health using special photographs.